SCHEMBL8539712

SCHEMBL8539712

NC(=O)Cn1c(=O)c(=O)[nH]c2ccccc21

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIA1 P42261 4/20 0.62
GRIA2 P42262 4/20 0.62
GRIA3 P42263 4/20 0.62
GRIA4 P48058 4/20 0.62
HPGD P15428 2/20 0.48
MPO P05164 3/20 0.47
PARP1 P09874 1/20 0.46
MEN1 O00255 1/20 0.45
CYP1A2 P05177 1/20 0.45
KMT2A Q03164 1/20 0.45
GRIN2D O15399 2/20 0.44
GRIN3B O60391 2/20 0.44
GRIN1 Q05586 2/20 0.44
GRIN2A Q12879 2/20 0.44
GRIN2B Q13224 2/20 0.44
GRIN2C Q14957 2/20 0.44
GRIN3A Q8TCU5 2/20 0.44
KDM4E B2RXH2 2/20 0.44
LMNA P02545 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4704936 0.86 GRIA1 (0.63) GRIA1GRIA2GRIA3GRIA4PARP1
SCHEMBL31653996 0.86 GRIA1 (0.63) GRIA1GRIA2GRIA3GRIA4PARP1
SCHEMBL9396483 0.81 KDM4E (0.72) GRIA1GRIA2GRIA3GRIA4HPGD
SCHEMBL24335550 0.78 GRIA1 (0.57) GRIA1GRIA2GRIA3GRIA4HPGD
SCHEMBL29580203 0.78 GRIA1 (0.57) GRIA1GRIA2GRIA3GRIA4HPGD
SCHEMBL9395583 0.77 GRIA1 (0.54) GRIA1GRIA2GRIA3GRIA4HPGD
SCHEMBL5551602 0.77 KDM4E (0.52) GRIA1GRIA2GRIA3GRIA4MPO
SCHEMBL982104 0.77 CYP1A2 (0.69) GRIA1GRIA2GRIA3GRIA4PARP1
SCHEMBL29579885 0.77 CYP1A2 (0.69) GRIA1GRIA2GRIA3GRIA4PARP1
SCHEMBL24335150 0.75 ALDH1A1 (0.56) GRIA1GRIA2GRIA3GRIA4HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0315959-B1 Quinoxaline compounds and their preparation and use NOVO NORDISK AS (DK) 1994-03-02 EP claimed
EP-0873321-A1 NOVEL AMIDO QUINOXALINE DIONES, THEIR PRODUCTION AND USE BASF AKTIENGESELLSCHAFT (DE) 1998-10-28 EP disclosed
US-5773439-A Amido-quinoxalinediones, the preparation and use thereof BASF AKTIENGESELLSCHAFT (DE) 1998-06-30 US disclosed
WO-1995035289-A1 NOVEL AMIDO QUINOXALINE DIONES, THEIR PRODUCTION AND USE BASF AKTIENGESELLSCHAFT (DE) 1995-12-28 WO disclosed
EP-0315959-B1 Quinoxaline compounds and their preparation and use NOVO NORDISK AS (DK) 1994-03-02 EP disclosed
US-5026704-A Neuroleptic agent, quisqualate-antagonist NOVO NORDISK A/S (DK) 1991-06-25 US disclosed
US-4948794-A NEUROLEPTIC AGENTS A/S FERROSAN (DK) 1990-08-14 US disclosed
EP-0315959-A2 Quinoxaline compounds and their preparation and use NOVO NORDISK A/S (DK) 1989-05-17 EP disclosed